✦ LIBER ✦

Antibodies against advanced glycation end product Nɛ-(carboxymethyl)lysine in healthy controls and diabetic patients

✍ Scribed by D. Vay; M. Vidali; G. Allochis; C. Cusaro; R. Rolla; E. Mottaran; G. Bellomo; E. Albano

Publisher: Springer
Year: 2000
Tongue: English
Weight: 97 KB
Volume: 43
Category: Article
ISSN: 0012-186X
DOI: 10.1007/s001250051543

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neuronal and glial advanced glycation en

Neuronal and glial advanced glycation end product [Nε-(carboxymethyl)lysine] in Alzheimer's disease brains

✍ Akinori Takeda; Masakazu Wakai; Hisayoshi Niwa; Rika Dei; Masahiko Yamamoto; Mei 📂 Article 📅 2001 🏛 Springer-Verlag 🌐 English ⚖ 289 KB

Plasma protein advanced glycation end pr

Plasma protein advanced glycation end products, carboxymethyl cysteine, and carboxyethyl cysteine, are elevated and related to nephropathy in patients with diabetes

✍ Ahmed A. Mostafa; Edward W. Randell; Sudesh C. Vasdev; Vicki D. Gill; Yingchun H 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 210 KB

Advanced glycation end products in diabe

Advanced glycation end products in diabetic patients with optimized glycaemic control and their effects on endothelial reactivity: possible implications in venous graft failure

✍ Massimo Chello; Cristiano Spadaccio; Mario Lusini; Elvio Covino; Carla Blarzino; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 311 KB

## Abstract ## Background Diabetic patients exhibit an increased risk of saphenous graft occlusion after coronary bypass. Advanced glycation end products (AGEs) are ubiquitous signalling proteins that are associated with vascular and neurological complication of diabetes. The aim of this study is